Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Photo story: GSK’s 2012 legacy

May 30, 2012 Research and Development Andrew Witty, GSK, Olympics 2012

Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …
Feature

GSK starts combination trial for melanoma

May 30, 2012 Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma

GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs.  The firm will combine dabrafenib, its …
News

UK Prix Galien shortlist announced

May 30, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Bayer, Janssen, Xarelto, awards, prix galien

The UK award for the most innovative new drug has been moved a step closer with the release of a …
News
brian_jolly_at_onyx_scientific_

Onyx appoints Brian Jolly to commercial team

May 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing CMO, Onyx, manufacturing

Onyx Scientific the chemistry and manufacturing specialist has bolstered its business development team with the appointment of a new director. …
Appointment

Sanofi/Regeneron cholesterol drug reaches Phase III

May 29, 2012 Research and Development, Sales and Marketing Amgen, PCKS9, Regeneron, SAR236553, Sanofi

Sanofi and Regeneron’s anti-cholesterol drug has impressed in a mid-stage trial, and will now progress into Phase III.  The firms’ …
News

Lundbeck’s Alzheimer’s drug shows promise

May 29, 2012 Research and Development, Sales and Marketing Alzheimer's, Lundbeck

Lundbeck’s Alzheimer’s candidate Lu AE58054 has shown signs in a phase II study of helping patients’ mental activity. Sufferers receiving …
News
Pradaxa image

European OK for Pradaxa, but more details required

May 29, 2012 Research and Development, Sales and Marketing Boehringer, CHMP, EMA, Europe, Pradaxa

The European Medicines Agency says that Boehringher’s Pradaxa can stay on the market, but will need more safety information.  The …
News

Life bolsters its client services team with two additions

May 28, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Life Healthcare Communications has developed its client services team with two new appointments to further support the needs of its …
Appointment

Pfizer appoints two senior roles

May 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, Read

Pfizer has named Olivier Brandicourt as president and general manager of its Emerging Markets and Established Products Business Units, and …
Appointment

Boehringer’s COPD drug passes hurdle

May 23, 2012 Research and Development, Sales and Marketing Boehringer, COPD, Daxas, Relovair, Spiriva, olodaterol

Boehringer Ingelheim’s once-daily bronchodilator olodaterol has improved lung function versus placebo in a Phase II trial.  The manufacturer wants the …
News
Doctor laptop image

Medical education: pharma’s evolving relationship with healthcare professionals

May 23, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Conference, InPharm, MEP, medical education

There are at least two perspectives of what ‘Medical Education’ means, and certainly many definitions.For doctors and other healthcare professionals, …
Feature

AMRI announces president for AMRI Europe

May 23, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AMRI, AMRI Europe, CMO

Contract research and manufacturing organisation AMRI has announced the appointment of Ian Shott as president of AMRI Europe.  In this …
Appointment
oliver_leatham

MSI appoints new market access consultant

May 22, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, appointment, market access

Strategic marketing firm The MSI Consultancy has appointed Oliver Leatham as market access consultant. Oliver has a wide experience as …
Appointment

Pharma R&D model no help to developing countries

May 22, 2012 Research and Development, Sales and Marketing HIV, MSF, Médecins Sans Frontières, R&D

Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …
News

UCB signs new epilepsy research pact with Imperial

May 21, 2012 Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy

UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026